www.endoquestrobotics.comHealthcare / Medical DevicesFounded: 2016Funding to Date: $332.96MM
EndoQuest Robotics is a medical equipment manufacturing company. With a mission to help healthcare providers perform minimally invasive surgical procedures, the manufacturing company has created an endoluminal robotic surgical system to provide flexibility in endoscopies. The microsurgical devices the company uses allow health professionals to access key parts of the body in single-incision surgeries to minimize any potential complications. EndoQuest Robotics was founded by Kurt Azarbarzin in 2017 and is headquartered in Houston, TX.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/29/2024 | Series D-1 | $20MM | $xx.xx | $29.76MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
229,428,837
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/04/2023 | Series C-1 | $42MM | $xx.xx | $270.68MM | Ce Ventures Limited, Mcnair Interests Ltd, Puma Venture Capital Llc | |
Price per Share
$xx.xx
Shares Outstanding
18,091,746
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ce Ventures Limited, Mcnair Interests Ltd, Puma Venture Capital Llc
|
||||||
05/15/2021 | Series C | $76.08MM | $xx.xx | $262.62MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
32,770,611
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/01/2021 | Series B-1 | $12.59MM | $xx.xx | $125.1MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,422,767
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/15/2019 | Series B | $11.15MM | $xx.xx | $52.45MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
11,082,382
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/01/2017 | Series A | $14.67MM | $xx.xx | $29.33MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
17,600,026
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|